Facebook Pixel Progcap Fintech Looks Beyond Lending, Eyes SaaS | Mint Chennai – newspaper – Lesen Sie diese Geschichte auf Magzter.com
Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Progcap Fintech Looks Beyond Lending, Eyes SaaS

Mint Chennai

|

July 30, 2025

Revenue from the SaaS and embedded credit vertical is likely to be 10-15% over the next two to three years

- Mansi Verma

Progcap, a fintech company focused on small businesses, is setting up a new vertical that will digitize their supply chains and offer them on-the-spot credit. It is building a full-stack software-as-a-service (SaaS) platform for brands, distributors and retailers, expanding from pure-play lending into embedded finance as a second revenue source, co-founders Pallavi Shrivastava and Himanshu Chandra told Mint.

WEITERE GESCHICHTEN VON Mint Chennai

Mint Chennai

Mint Chennai

Barrier-free tolling runs into a Chinese camera security bump

Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.

time to read

1 min

February 26, 2026

Mint Chennai

A new grammar to challenge Tamil film

Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham

time to read

3 mins

February 26, 2026

Mint Chennai

AUROBINDO PHARMA TAKES A PENICILLIN SHOT

The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?

time to read

6 mins

February 26, 2026

Mint Chennai

Digital rupee pilot for food subsidy

In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.

time to read

1 min

February 26, 2026

Mint Chennai

DRL's obesity jab may launch in March

Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.

time to read

1 min

February 26, 2026

Mint Chennai

Mint Chennai

Uranium supply deal likely during Carney’s India visit

Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Warner interested in Paramount offer

Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

Hype and havoc shroud Al's impact on IT firms

Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Zydus plans obesity jab in pens after semaglutide patent ends

Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER

Most investors enter equity mutual funds expecting an annual average return of about 12%.

time to read

3 mins

February 26, 2026

Listen

Translate

Share

-
+

Change font size